Deepa Mokshagundam

Deepa Mokshagundam

Auto-generated profile, based on publicly available information

Deepa Mokshagundam

Department of Cardiology, St. Louis Children's Hospital, St Louis, Missouri

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
JEJonathan B Edelson
Jonathan B Edelson
ARAlexander Raskin
Alexander Raskin
MAMohammed Absi
Mohammed Absi
IAIki Adachi
Iki Adachi
OAOthman Aljohani
Othman Aljohani
ACAction Collaborators
Action Collaborators

19 September 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
DNDeipanjan Nandi
Deipanjan Nandi
SAScott R. Auerbach
Scott R. Auerbach
NBNeha Bansal
Neha Bansal
HBHolger Buchholz
Holger Buchholz
JCJennifer Conway
Jennifer Conway
CVChet R. Villa
Chet R. Villa

3 February 2025 in Pediatric Transplantation
Verified
Journal Article
Closed access
EHEmily A. Hayes
Emily A. Hayes
DKDevin Koehl
Devin Koehl
RCRyan Cantor
Ryan Cantor
LFLauren A. Fisher
Lauren A. Fisher
EAEstela Azeka
Estela Azeka
GBGerard J. Boyle
Gerard J. Boyle

27 May 2023 in ASAIO Journal
Verified
Journal Article
Closed access
KBKaterina Boucek
Katerina Boucek
AAAnaam Alzubi
Anaam Alzubi
FZFarhan Zafar
Farhan Zafar
MOMatthew J. O’cOnnor
Matthew J. O’cOnnor
MMMary Mehegan
Mary Mehegan
DRDavid N. Rosenthal
David N. Rosenthal
We sought to develop a contemporary risk assessment tool for use in pediatric ventricular assist device (VAD) candidates to estimate risk for mortality on the device using readily available preimplantation clinical data. Training and testing datasets were created from Advanced Cardiac Therapies Improving Outcomes Network (ACTION) registry data on patients supported with a VAD from 2012 to 2021. Potential risk factors for mortality were assessed and incorporated into a simplified risk prediction model utilizing an open-source, gradient-boosted decision tree machine learning library, known as random forest. Predictive performance was assessed by the area under the receiver operating characteristic curve in the testing dataset. Nine significant risk factors were included in the final predictive model which demonstrated excellent discrimination with an area under the curve of 0.95. In addition to providing a framework for establishing pediatric-specific risk profiles, our model can help inform team expectations, guide optimal patient selection, and ultimately improve patient outcomes.

2 July 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
JMJiyong Moon
Jiyong Moon
LGLawrence Greiten
Lawrence Greiten
CVChristina VanderPluym
Christina VanderPluym
DPDavid M. Peng
David M. Peng
ABArene Butto
Arene Butto
MOMatthew J. O’cOnnor
Matthew J. O’cOnnor

18 March 2025 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
DMDeepa Mokshagundam
Deepa Mokshagundam
DRDavid N. Rosenthal
David N. Rosenthal
LSLauren Smyth
Lauren Smyth
ALAngela Lorts
Angela Lorts
Progress in the field of pediatric ventricular assist devices (VAD) have revolutionized the care and management of young patients with end-stage heart failure. However, innovation in pediatric medical devices is limited by financial and regulatory barriers due to the small and heterogenous target population. The Advanced Cardiac Therapies Improving Outcomes Network (ACTION) was established in 2017 as a learning network to improve outcomes of pediatric patients supported on VAD. Here we describe how intentional design of the ACTION registry has mitigated regulatory and financial barriers to pediatric VAD innovation through the use of real-world evidence gathered through a learning network.